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Abstract: The life cycles of retroviruses rely on the limited proteolysis catalyzed by the viral 
protease. Numerous eukaryotic organisms also express endogenously such proteases, which 
originate from retrotransposons or retroviruses, including DNA damage-inducible 1 and 2 (Ddi1 
and Ddi2, respectively) proteins. In this study, we performed a comparative analysis based on the 
structural data currently available in Protein Data Bank (PDB) and Structural summaries of PDB 
entries (PDBsum) databases, with a special emphasis on the regions involved in dimerization of 
retroviral and retroviral-like Ddi proteases. In addition to Ddi1 and Ddi2, at least one member of all 
seven genera of the Retroviridae family was included in this comparison. We found that the studied 
retroviral and non-viral proteases show differences in the mode of dimerization and density of 
intermonomeric contacts, and distribution of the structural characteristics is in agreement with their 
evolutionary relationships. Multiple sequence and structure alignments revealed that the 
interactions between the subunits depend mainly on the overall organization of the dimer interface. 
We think that better understanding of the general and specific features of proteases may support 
the characterization of retroviral-like proteases. 
Keywords: retrovirus; retrovirus-like; protease; retroviral protease; dimerization; comparative 
analysis; contact map; DNA damage-inducible protein; Ddi1; Ddi2 
 
1. Introduction 
Retroviral aspartic proteases, also referred to as retropepsins, belong to family A2 of aspartic 
proteases. The most characteristic member of this family is the protease (PR) of human 
immunodeficiency virus type 1 (HIV-1). The viral protease plays a significant role in the replication 
cycles of retroviruses by processing the viral Gag and Gag-Pol polyproteins. This limited proteolysis 
is an essential event of the viral life cycle; thus, the viral proteases have become important targets of 
antiviral therapies. 
Retropepsins share their main characteristics. First, they use the same catalytic mechanism, and 
hydrolysis of the peptide bond is catalyzed by a dyad of highly conserved catalytic Asp residues 
located in the consensus D-T/S-G-A active site motif. The structural similarities of retropepsins to 
aspartic protease pepsin implied that they are evolutionarily related to each other. However, in 
contrast to the bilobal monomeric pepsin, retroviral proteases function as homodimers, and the 
dimerization is a prerequisite for their activity [1,2]. In addition to the active site motif, other 
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structurally important regions, which are involved in dimer formation, are also shared by the PRs as 
follows: (i) flap region, (ii) active site loop residues (‘fireman’s grip’ interactions), (iii) dimer interface 
platform at the bottom of the homodimeric protease, and (iv) consensus α-helix near the C-terminus 
of the enzyme (Figure 1).  
 
Figure 1. Retroviral and DNA damage-inducible (Ddi) proteins share their main characteristics. 
Overall structures of human immunodeficiency virus type 1 (HIV-1, PDBID: 5HVP) and human DNA 
damage-inducible protein 1 ((Ddi1-Hs) (PDBID: 3S8I) proteases are shown. Arrows show important 
regions, with the exception of the additional α-helical insert, these regions are known to contribute to 
dimerization. 
Numerous eukaryotic organisms have been found to express homologs of retrovirus and 
retroelement PRs, which evolved from their ancestors and which were retained during their 
evolution [3,4]. Despite the low sequence identity, retropepsins exhibit high structural similarity, 
suggesting that the eukaryotic homologs may also share their overall fold and main features with 
retropepsins. Substantial structural information is available for DNA damage-inducible protein 1 and 
2 (Ddi1 and Ddi2, respectively), which are eukaryotic proteins containing a retroviral-like aspartic 
protease domain [5–8]. 
Since the report of the first retroviral PR structures in 1989 [9], several protease structures have 
been solved, and with the exception of the Epsilonretrovirus genus, the structure of at least one 
member of other six retrovirus genera has already been determined (Table 1A). In the Protein Data 
Bank (PDB) database, lentivirus PRs are overrepresented, and HIV-1 PR is the most extensively 
studied member of the Retroviridae family [10] (Table 1A). Although numerous retroviral PRs have 
been characterized in vitro to date, no experimental data are available for some PRs regarding their 
structure or activity, e.g., bovine immunodeficiency virus (BIV), caprine arthritis encephalitis virus 
(CAEV), Maedi visna virus, jaagsiekte sheep retrovirus (JSRV), or squirrel monkey retrovirus (SMRV) 
[11]. 
Compared with the available data for retroviral PRs, the structures of only few retroviral-like 
aspartic PRs have been experimentally solved to date. The protease domain of Saccharomyces cerevisiae 
Ddi1 protein (Ddi1-Sc) was the first retroviral-like PR for which its structure was determined by X-
ray crystallography [5], and the crystal structures of human Ddi1 (Ddi1-Hs), Leishmania major Ddi1 
(Ddi1-Lm) and human Ddi2 proteases (Ddi2-Hs) were later reported (Table 1B). 
Despite the low sequence identity between the target and template structures, retroviral and 
retroviral-like PRs exhibit high structural similarity [5], which makes the homology modeling of 
retroviral-like PRs possible. Before the deposition of the first Ddi1-Lm crystal structure to the PDB in 
2017 [8], model structures were previously prepared for Ddi1-like PR of L. major [5,12,13], and the 
PRs of Schistosoma mansoni and Hymenolepis microstoma [13]. 
  
Int. J. Mol. Sci. 2020, 21, 1352 3 of 24 
 
Table 1. Retroviral and retroviral-like PRs in Protein Data Bank. Coordinate files available in the PDB 
are shown for retroviral (A) and Ddi1/Ddi2 retroviral-like PRs (B). Only some representative PDB IDs 
are presented if >10 coordinate files are available. For HIV-1, only an approximate value is shown, 
based on a refined search on text-(on ‘HIV-1 protease’) and structure title-search (on ‘HIV-1′ and 
‘protease’). Database was accessed in October 2019. 
(A) 
Retrovirus Genus Representative Virus Name 
Number 
of IDs 
PDB ID Reference  
Lentiviruses 
Human Immunodeficiency 
virus type 1 
HIV-1 >600 
5HVP [14] 
1G6L [15] 
3PHV [16] 
1ZTZ [17] 
4LL3 [18] 
7HVP [19] 
5YOK [20] 
4Z4X [21] 
1TW7 [22] 
Human Immunodeficiency 
virus type 2 
HIV-2 19 
1HII [23] 
5UPJ, 6UPJ [24] 
2HPE 
to be 
published 
3EBZ [25] 
Equine infectious anemia 
virus 
EIAV 2  
1FMB [26] 
2FMB [27] 
Simian Immunodeficiency 
virus 
SIV 7 
1SIV [28] 
1TCW [29] 
1YTI, 1YTJ, 1YTH, 1YTG [30] 
1AZ5 [31] 
Feline immunodeficiency 
virus 
FIV 10 
4FIV [27] 
1FIV [32] 
2FIV, 3FIV [33] 
5FIV, 6FIV, 1B11 [34] 
2HAH [35] 
3OGP, 3OGQ [36] 
Spumaretroviruses Simian Foamy virus SFV 1 2JYS [37] 
Alpharetroviruses 
Avian myeloblastosis virus AMV 1 1MVP [38] 
Rous Sarcoma Virus RSV 2 
1BAI [39] 
2RSP [40] 
Deltaretroviruses 
Human T-lymphotropic virus 
type 1 
HTLV-1 10 
3LIY, 3LIX, 3LIV, 3LIQ, 3LIN, 3LIT [41] 
3WSJ, 4YDF, 4YDG [42] 
2B7F [43] 
Epsilonretroviruses 
Walleye epidermal 
hyperplasia virus type 1 
WEHV-1 0 - - 
Gammaretroviruses 
Xenotropic murine leukemia 
virus-related virus 
XMRV 5 
4EXH [44] 
3SLZ, 3SM1, 3SM2 [45]  
3NR6 [46]  
Betaretroviruses Mason–Pfizer monkey virus MPMV 5 
6S1U, 6S1W, 6S1V [47] 
3SQF [48] 
1NSO [49] 
(B) 
Protein Organism Name IDs PDB ID Reference  
Non-viral 
(eukaryotic) 
Saccharomyces cerevisiae Ddi1-Sc 2 
2I1A [5] 
4Z2Z [7] 
Homo sapiens  
Ddi1-Hs 1 3S8I 
to be 
published 
Ddi2-Hs 1 4RGH [6] 
Leishmania major Ddi1-Lm 2 5YS4, 5YQ8 [8] 
It is known that dimerization is an obligate requirement for retropepsin activity. Using substrate-
dependent methods, dimer stabilities can be investigated in vitro by determining the urea 
concentration leading to a 50% loss in enzymatic activity (UC50), or the apparent dimer dissociation 
constant (Kdapp) can be determined by measuring enzyme activity at increasing enzyme 
concentrations, the consequence of less-efficient dimerization is a decreased activity at lower enzyme 
concentrations. Using kinetic assays, dimer stabilities have already been determined only for some 
retroviral PRs (Table S1), including wild-type and mutant HIV-1 PRs [44,50–53], HIV-2 PR [54], 
xenotropic murine leukemia virus-related virus PR (XMRV PR) [44], human foamy virus PR (HFV 
PR) [55], human T-lymphotropic virus type 1 PR (HTVL-1 PR) [56], avian myeloblastosis virus (AMV) 
and Mason–Pfizer monkey virus (MPMV) PRs [53]. Substrate-independent methods are also 
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available for the investigation of dimerization, including thermal denaturation, analytical 
ultracentrifugation, or circular dichroism [53,57–59]. 
Functional studies have already revealed the importance of Ddi-like proteases. Studies on wild-
type and active site mutant Ddi1-Lm proteins revealed changes of the secretion phenotype, and their 
sensitivity to HIV PR inhibitors also implied the existence of catalytic activity [60]. Studies on Ddi1-
Sc PR provided evidence for its proteolytic activity, which was found to be required for sufficient 
checkpoint regulation [61] and to contribute to protein secretion [62], DNA replication stress response 
[63], and DNA-protein crosslink repair [64]. In Caenorhabditis elegans, Ddi1 expression was found to 
be induced by proteasome dysfunction; furthermore, results proved that the catalytic activity of Ddi1 
PR is necessary for protein activation [65], and involvement of PR activity in Nrf1 processing was 
also demonstrated for human Ddi2 PR [66,67]. Protease domain of Ddi1-Hs protein was found to 
undergo post-translational modification, ubiquitination sites were identified in the proximities of the 
active site (K192) and the dimer interface (K382) [68], but effect of these modifications of protease 
function has not been elucidated. Among the Ddi-like PRs, proteolytic activity of a recombinant 
protein was proved in vitro only for Ddi1-Lm [12]. Despite using various methods (e.g., screening an 
HEK293 cell line-derived peptide library or cleavage reactions by oligopeptide or protein substrates), 
neither the autoproteolytic activity (cis-activity) nor cleavage of any target protein (trans-activity) has 
been observed for purified Ddi2-Hs [6] and Ddi1-Sc [5,7] proteases. These studies implied that 
putative specific factors or determinants may be necessary for PR activation, which remained to be 
elucidated.  
We propose that in addition to putative specific cellular factors, special structural features may 
also be important determinants of dimerization. Because of missing experimental data, we 
investigated dimerization purely based on the structural information currently available in the PDB 
and PDBsum databases and compared the main characteristics of retroviral PRs and the eukaryotic 
homolog Ddi1/Ddi2 PRs. To our knowledge, comparative analyses have been conducted only for 
retroviral PRs [9,69–71] and Ddi1-like PRs [13], but retroviral and non-viral PRs have not been 
compared in such analyses. While comparative analyses of retroviral PRs may support 
understanding of mutational capacity of HIV-1 PR and resistance development [70], exploring 
general and specific features of retroviral and retroviral-like PRs may support characterization of 
retroviral-like PRs with unknown structures and the identification of efficient inhibitors e.g., against 
Ddi2-Hs PR [67]. Here we describe a comparison of overall structural structures and contact maps, 
with a special emphasis on the regions involved in dimerization and the correlation of the key 
features with the evolutionary relationships. 
2. Results 
2.1. Phylogenetic Analysis 
Evolutionary relationships were investigated by multiple alignment of PR sequences and 
structures. In the comparison, all seven genera of exogenous retroviruses were represented, and a 
previously prepared set of retroviral PRs [70,72,73] was complemented with eukaryotic Ddi1 and 
Ddi2 retroviral-like PRs with experimentally determined structures. The result of the sequence-based 
analysis is shown later in the Discussion. 
A structure-based comparison was also performed, at least one member of each retrovirus genus 
was represented (Figure 2A). Coordinate files of most retroviral PRs and Ddi eukaryotic homologs 
were downloaded from the PDB database, with the exception of epsilonretrovirus PRs (Table 1), 
whose structures has not been determined experimentally to date. Therefore, a coordinate file for a 
homodimeric Walleye epidermal hyperplasia virus type 1 (WEHV-1) PR was obtained by automated 
homology modeling (Figure 2B), using the SWISS-MODEL web server, and the proposed structure 
was used for multiple structure alignment. The structure-based phylogenetic tree was generated 
using the mTM-align server based on pairwise template modeling scores [74]. 
The phylogenetic relationships revealed by the multiple structure alignment closely resembled 
those obtained by the sequence-alignment, and they were in good agreement with those determined 
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using whole viral sequences [75]. Gamma- and epsilonretroviruses were found to be distantly related 
to lentiviruses, alpha-, beta- and deltaretroviruses, whereas spumaretroviruses exhibited closer 
relationships with the non-viral Ddi proteins (Figure 2A). The structural characteristics of proteases 
showed no full correlation with the complexities of retroviral genomes because alpha-, beta-, gamma- 
and epsilonretroviruses have simple genomes, whereas lentiviruses, delta- and spumaretroviruses 
have complex genomes. 
Based on the phylogenetic trees, we assumed that the structural characteristics correlate with 
the evolutionary relationships of the proteases. Thus, the results of structure-based alignment (Figure 
2C) were used to explore general similarities and differences in detail by focusing mainly on the 
regions that are important determinants of dimerization. 
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Figure 2. Structure-based phylogenetic analysis of proteases. (A) Phylogenetic tree was prepared via 
the multiple alignment of PR structures (PDBIDs are shown) using the mTM-Align web server. (B) 
Overall structures of representative PRs are shown, PDBIDs are also indicated. Homology model is 
shown for Walleye epidermal hyperplasia virus type 1 (WEHV-1) PR, homodimeric equine infectious 
anemia virus (EIAV) and simian foamy virus (SFV) PRs are shown by aligning the monomers to a 
homodimeric HIV-2 PR structure (PDBID: 1HII). Other structures are represented based on their 
crystal structures. Structures are colored according to their secondary structures: β-strand, yellow; α-
helix, red; 310-helix, green. Arrows indicate additional α-helical inserts. (C) Multiple structure 
alignment of proteases is shown according to the results of analysis performed using mTM-Align web 
server. Sequences of aligned structures are colored according to the arrangement of secondary 
structural elements: β-strands, orange; α-helix, red; and 310-helix, green. Active site motif residues are 
shown in bold. Secondary structural elements are shown according to the Dictionary of protein 
secondary structure (DSSP) images of PDB, and based on homology model structure for WEHV-1 PR. 
2.2. Dimer Interface Organization 
First, we compared the overall organization of the dimer interface, which is a β-sheet platform 
at the bottom of most PRs (Figure 1). Based on the known structures, three main types of dimer 
interfaces can be differentiated, and we used the following classification of the dimer interfaces. 
The type I dimer interface consists of alternating N- and C-terminal strands and corresponds to 
the prototypic interface of lentivirus (e.g., HIV-1), betaretrovirus (e.g., MPMV-1), alpharetrovirus 
(e.g., AMV-1) and deltaretrovirus (e.g., HTLV-1) proteases (Figure 3). 
The type II interface contains exclusively C-terminal β-strands that are not interdigitated. Based 
on the number of strands, this interface type can be subdivided into two subgroups. Four- and six-
stranded dimer interfaces can be differentiated, as described for XMRV and Ddi1 PRs, respectively 
(Figure 3).  
Similarly to type II, the type III interface also exclusively consists of C-terminal regions but 
exhibits remarkably different organization. Specifically, the regions forming the interface have a 
helical arrangement instead (Figure 3). To date, the simian foamy virus (SFV) is the only retrovirus 
that was experimentally proved to have a PR displaying this unusual mode of dimerization [76]. 
 
Figure 3. Classification of dimer interfaces. Dimer interfaces are represented according to selected 
structures, PDBIDs are shown for each protease. Homology model is shown for WEHV-1 PR. 
Structure of homodimeric SFV PR was proposed by aligning the monomers to a homodimeric HIV-2 
PR structure (PDBID: 1HII). Subunits are colored by green and cyan. 
The orientation of the strands in the β-sheet platforms was previously found to depend on the 
overall organization of the interface [5,46], and both the four- and six-stranded dimer interfaces 
showed rotations of the strands around the dimer axis compared to those of HIV-1 PR (Figure 3). The 
rotation of the strands relative to the enzyme’s core is different in Ddi1 compared with that in HIV-1 
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PR, but it is similar to the topology of the β-sheets (approximately 45° rotation) of non-viral aspartic 
protease pepsin [2]. 
The gammaretrovirus XMRV PR is the only retroviral PR that was found to contain a four-
stranded dimer interface [46], whereas crystal or solution structures have not revealed such an 
interface in other retroviral PRs to date. We have prepared a homology model for the WEHV-1 PR, 
and the results of both the secondary structure prediction and template search suggested highest 
similarity to XMRV PR, and the same dimer interface organization. Thus, we propose that WEHV-1 
PR (and WDSV PR, as well) shares the same four-stranded dimer interface organization as XMRV PR 
(Figure 3). 
Of the studied proteases, only Ddi PRs were found to have six-stranded dimer interfaces (Figure 
3), and based on the currently available structural data this dimer interface organization is not 
characteristic of retroviral PRs. Analysis of additional enzymes may reveal whether this dimer 
interface organization is a specific feature of eukaryotic retroviral-like PRs. 
Structural and biochemical studies also suggested that SFV PR has a specific mode of 
dimerization that is significantly different from that of other retroviral and retroviral-like PRs [76]. 
Similarly to epsilonretrovirus, gammaretrovirus and Ddi1/Ddi2 PRs, the N-terminal region of SFV 
PR is not involved in dimer formation because the presence of N- and C-terminal proline residues 
makes the formation of dimer interface strands unfavorable [37,76]. In the solution structure of SFV 
PR, a short α-helix is present instead of a C-terminal β-strand [37], and it does not overlap with the 
consensus helix of HIV-1 PR. The helix in SFV PR near the C-terminus is in the same position at which 
a β-strand of the dimer interface is found in the HIV-1 PR structure (Figure 2C). In agreement with 
this, our secondary structure predictions also implied that foamy virus PRs may have unusual dimer 
interface (Figure S1). None of the applied algorithms predicted the presence of N- or C-terminal 
terminal β-strands that correspond to the strands of type I or type II dimer interfaces. Interestingly, 
the helical arrangements of the C-terminal regions were predicted, but this extension is not visible in 
the solution structure of SFV PR (Figure 3). 
A putative homodimer is represented for SFV PR in Figure 2B. Similarly to a previously 
proposed dimer [76], this model should only be considered hypothetical because the full-length 
interface is not visible in the solution structure, and the conformations of the longer helical extensions 
are hardly predictable without proper template structures. Interestingly, the involvement of C-
terminal regions in dimer formation also appears to be unique. In vitro activity assays revealed that 
both the full-length (1–143) and C-terminally truncated (1–101) forms of the protease possess enzyme 
activity [37,76]. Based on this finding, the elongated C-terminal regions contribute to dimer 
stabilization. However, they can provide lower dimer stability as compared to HIV-1 PR (Table S1), 
are not prerequisites for enzyme activity. 
Altogether, these results prove the existence of a type III dimer interface that provides 
dimerization without N- or C-terminal β-strands. This type of interface platform is significantly 
different from that of retroviral and Ddi1/Ddi2 PRs, and to date appears to be a unique feature of 
foamy virus PRs. 
2.3. Intermonomeric Interactions 
Contact maps of homodimeric PRs were obtained from the PDBsum database, and the areas of 
intersubunit interfaces (Å) and the total numbers of interface residues, H-bonds and non-bonded 
contacts were compared (Figure 4). The investigated parameters were found to vary among the 
different PRs, exhibiting correlations with the phylogenetic relationships. It is important to note that 
the numbers of currently available structural data are different, and for some proteases, only few 
structures are available (e.g., AMV, Rous sarcoma virus (RSV), and equine infectious anemia virus 
(EIAV) PRs); therefore, differences of sample numbers were considered while choosing algorithm for 
statistical analysis. The coordinate files used for the analysis are listed in Table S2. 
The contact densities of XMRV and Ddi PRs were found to be similar but lower than those of 
the other studied PRs. The difference was statistically significant in almost all cases (Table S3). 
Although, a larger interface area and higher interface residue number were determined for XMRV 
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PR, the numbers of H-bonds and non-bonded contacts were more comparable with those of Ddi 
proteins. The contribution of the β-sheet platform to dimer formation is not exclusive, but it provides 
the main part of the intersubunit interactions. The observed differences of contact densities exhibited 
obvious correlations with the organization of the dimer interface. Specifically, the contact numbers 
were significantly lower in XMRV and Ddi PRs possessing four- and six-stranded type II interfaces, 
respectively, than in other studied PRs containing type I interface (Figure 4). Data for homodimeric 
foamy virus PRs are not available currently in PDBsum database, thus, spumaretrovirus PRs were 
not included in the comparison. 
 
Figure 4. Comparison of overall contact maps. Boxplots represent the means of the total interface area 
(A), number of interface residues (B), number of H-bonds (C) and number of non-bonded contacts 
(D). Data were plotted by using PAST v3.26 software. Error bars represent SD. Statistical analysis was 
performed using ANOVA (Mann–Whitney pairwise) algorithm, raw p values are shown in Table S3. 
The values determined for HIV-1, HIV-2, SIV, and FIV PRs were highly similar, indicating that 
lentivirus PRs share comparable intermonomeric contacts (Figure 4). Within the Lentivirus genus we 
observed statistically significant differences only in some cases (mainly for the number of non-
bonded contacts), but the overall contact densities resembled each other (Table S3). 
Values determined for HTLV-1 PR were also similar to those of lentivirus PRs, but a larger 
interface area and smaller density of non-bonded interactions were observed compared to HIV-1 PR 
(Figure 4), while the numbers of interacting residues and H-bonds were not significantly different 
(Table S3). We observed that XMRV PR has significantly lower contact density than HTLV-1 PR, 
which implied higher in vitro dimer stability for HTLV-1 PR. Despite this, the relatively higher Kdapp 
indicated that HTLV-1 PR has lower dimer stability than XMRV PR (Table S1). Therefore, the overall 
contact densities may not be obviously in agreement with the in vitro dimer dissociation constants, 
but the available information is limited. 
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Interestingly, alpharetrovirus PRs were found to have significantly higher number of 
intermonomeric H-bonds than other proteases, whereas other studied parameters were more 
comparable (Figure 4). The structure alignment illustrated that AMV and RSV PRs are longer than 
HIV-1 PR because of a two-residue-long C-terminal extension (N123 and L124 in each structure). 
Additionally, they contain a short insertion between the β-strands corresponding the sixth and 
seventh strands of HIV-1 PR, and consequently, the loop connecting the β-strands is closer to the 
dimer interface, permitting intersubunit interactions at this site. These interactions are missing from 
the bottom of HIV-1 PR (Figure S2) and are responsible in part for the higher number of H-bonds in 
AMV and RSV PRs. 
In addition to the overall differences and similarities of intermonomeric contacts, we analyzed 
the regions that are known to contribute to dimer formation in detail, and investigated differences in 
(i) ‘fireman’s grip’, (ii) the salt bridges formed near that catalytic site, (iii) the consensus α-helix and 
iv) the flaps. 
2.4. ‘Fireman’s Grip’ 
It is known that the Thr/Ser residues present in the conserved D-T/S-G-A active site motif of 
retroviral PRs are essential for dimer formation and stabilization via intermonomeric interactions 
referred to as ‘fireman’s grip’ [57]. The ‘fireman’s grip’ interactions provided by the hydroxyl group 
of Thr can be substituted by that of Ser, but higher Kdapp values were determined for HIV-1 and AMV 
PRs containing Ser in this position, proving the contribution of the Thr side chain to dimer formation 
and stabilization [53,57,77].  
We compared the active site motif sequences to investigate the conservation of Thr or Ser 
residues in retroviral PRs and in non-viral Ddi proteins.  
We found that Thr is highly conserved in the active site motifs of lentiviruses, beta-, delta-, 
epsilon- and gammaretrovirus PRs, whereas the residue may be either Thr or Ser in alpharetrovirus, 
spumaretrovirus, and Ddi PRs (Figure 5A). It was hypothesized that enzymes having looser 
‘fireman’s grip’ interactions exhibit lower dimer stability and activity [77].  
We found that the third residue of the D-T/S-G-A active site motif is highly conserved in both 
retroviral and retroviral-like PRs (Figure 5A). This glycine is replaced by glutamine in this position 
exclusively in FFV PR among the studied proteases (Figure S1). The Ddi1-like proteins of 
platyhelminth parasites were found previously to contain Ser in the active site motif [13], but among 
the studied Ddi PRs, Thr was found to be present only in Ddi1-Sc PR. 
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Figure 5. Intermonomeric interactions at the active site and consensus helix. (A) Sequence logos of 
active site motifs are shown. The formation of a salt bridge between the active site motif (Glu residue) 
and an N-terminal residue of the other subunit is denoted by ‘+’, whereas the absence of a salt bridge 
in the corresponding position is denoted by ‘-‘, as represented by structures of HIV-1 and XMRV PRs. 
(B) Sequence logos of consensus α-helices are shown. The involvement of consensus helix residues in 
H-bond formation is denoted by ‘+’ or ‘-‘. In the consensus helix, positively charged Arg and Lys 
residues can form H-bonds (red dotted lines) with the N-terminus of the other subunit, as shown for 
HIV-1 and Ddi2-Hs PRs, respectively. Sequence logos were prepared based on the sequences used for 
phylogenetic analysis. Residue interactions were determined on the basis of contact maps (PDBsum 
database) of the structures used for multiple structure alignment (Figure 2A). 
2.5. Active Site Motif 
In HIV-1 PR and in most retroviral PRs, the consensus D-T/S-G-A active site motif is followed 
by an Asp residue, which is known to be involved in dimer formation. In HIV-1 PR, a salt bridge is 
formed between this Asp and an Arg residue at the N-terminus of the other subunit (D29 and R8′ 
residues, according to the HIV-1 PR numbering) (Figure 5A). Mutagenesis of this Arg residue 
revealed that substitution by Gln causes only a slight decrease in activity compared with that of wild-
type HIV-1 PR, indicating that the ion pair contributes to but is not essentially required for dimer 
formation [78]. 
The sequence logos of the active site motif were compared, and we found that the PRs of 
lentiviruses, alpha-, beta- and deltaretroviruses, which are closely related to each other (Figure 2), 
exhibit high conservation of the Asp residue forming the salt bridge (Figure 5A), with the exception 
of BLV PR, which contains Glu in this position. Based on the contact maps, the Asp residue in these 
enzymes can form a salt bridge with an Arg residue of the other subunit. Interestingly, MPMV PR 
contains a Lys instead of Arg in its N-terminal region (R8 in HIV-1 PR) (Figure 2), but an ion pair can 
also be formed between this Lys and the Asp residues in the active site (Figure 5A). 
In contrast with this, epsilon-, gamma- and spumaretrovirus, and Ddi PRs contain different 
residues in this position, namely Cys or Gln in epsilonretrovirus and Ddi2 PRs, respectively. Glu, 
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Gln, and Thr are the most prevalent residues in gamma- and spumaretrovirus PRs, whereas Asp is 
present only in FFV PR in this position (Figure S1). XMRV and Ddi PRs contain Gln or Glu in this 
position, and the contact maps revealed no formation of salt bridges in their crystal structures (Figure 
5A). In accordance with the literature data [46], mainly hydrophobic contacts are formed between the 
subunits, which replace the ionic interactions. Based on PDBsum data, H-bonds are not formed by 
the fifth residue of the active site in these PRs, but non-bonded interactions are formed instead. 
Epsilonretrovirus proteases exclusively contain Cys in this position; thus, it can be expected that 
a salt bridge is not formed by this motif residue. All foamy PRs contain Thr after the consensus active 
site motif instead of Asp (Figure 5A); thus, based on sequences they also lack the intermonomeric ion 
pair. These data are in agreement with the higher dimer stability of HIV-1 PR compared with that of 
XMRV PR (Table S1) because of the contribution of salt bridges to dimer stabilization. 
2.6. Consensus α-Helix 
The structures of homodimeric retroviral and retroviral-like aspartic PRs share the same 
protease fold. Each subunit consists of mainly β-strands, but the presence of a consensus short α-
helix near the C-terminus is also a common feature that encompasses one of the most conserved 
sequence motifs of these enzymes. This α-helix contains G-R-N motif in HIV-1, HIV-2, and SIV PRs, 
whereas G-R-D motif is present in other lentivirus PRs and in all other retroviral genera members, 
excepting spumaretroviruses (Figure 5B).  
In HIV-1 PR, the side chain atoms of R87 residue have H-bond interactions with the main chain 
atoms of L5′ and W6′ residues [79]. The significance of these interactions was investigated previously 
via mutagenesis studies. The G86 residue was found to participate in the coordination of active site 
loop’s conformation, which is necessary for efficient substrate binding and proteolysis. In contrast 
with this, the neighboring R87, which makes intersubunit contacts, was found to contribute to dimer 
stabilization, as the R87K mutant protein had impaired ability for dimerization, and it was mainly 
monomeric in solution [79–81].  
These interactions of the side chain of Arg with the main chain atoms of one or two residues of 
the other subunit’s N-terminus can be observed in the structures of HIV-1, HIV-2, EIAV, SIV, FIV, 
AMV, RSV, and HTLV-1 PRs. The side chain of R95 in the G-R-N/D motifs of XMRV PR structures 
do not interact with the P14′ residues. Structure of WEHV-1 PR was built up based on that of XMRV 
PR; therefore, the model also revealed no R95 side chain-mediated interaction with the other subunit. 
It appears that pattern of interactions between the consensus C-terminal helix and N-terminal 
residues is different in the case of PRs with type I (e.g., HIV-1 and HTLV-1 PRs) or type II (e.g., Ddi1 
PRs) dimer interfaces. Ddi PRs contain a G-L-D-M-L-K/R sequence in the consensus helix, which 
lacks the Arg residue of the G-R-D conserved motif but contains a downstream positively charged 
residue (Lys or Arg) that is exposed to the intersubunit surface, such as R87 of HIV-1 PR). This residue 
can also form H-bonds with the N-terminus of the other subunit (Figure 5B). 
The C-terminal α-helix of SFV PR does not overlap with that of HIV-1 PR, as it is located closer 
to the C-terminus almost where a β-strand is found in the HIV-1 PR structure (Figure 2C). 
Additionally, the sequence motif of the consensus α-helix is completely different from those of 
retroviral and Ddi PRs, and no G-R-N/D motif is present in SFV PR. The difference in the sequence, 
especially the Arg-to-Pro substitution, makes the formation of the helix in the same position 
unfavorable [37]. This also proves that foamy virus PRs possessing type III interface exhibit 
significantly different distribution of intermonomeric interactions, which remain to be explored in 
detail by studies of homodimeric spumaretrovirus PRs. 
2.7. Flaps 
In retroviral PRs, the flaps have mainly β-hairpin conformation. Due to their flexibility they can 
adopt opened, semi-opened and closed conformations, which conformational changes contribute to 
substrate binding and product release, as well (Figure S3). Whereas the opened conformation permits 
ligand binding, in the closed conformation the flaps cover the active site, and in the ligand-bound 
state they wrap around the substrate (or inhibitor) [82].  
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In Ddi PRs, these regions—corresponding to the flaps of HIV-1 PR—adopt less-ordered 
conformational loops and exhibit higher flexibility; consequently, only one or none of the loops is 
visible in the known structures [5–8]. Contact maps proved that both the residue number and area of 
the interface are higher in the closed conformation. The number of H-bonds was almost identical in 
the different conformations and the number of non-bonded interactions was slightly lower in the 
opened conformation in the investigated HIV-1 PR structures (Figure 6A), due to the missing flap-
interactions. XMRV PR structures either containing or lacking full-length flaps were also compared, 
and we found to have remarkably larger interface area and higher contact density if the full-length 
flaps were present in the structure (Figure 6B), which further proved the role of flaps in the 
intermonomeric interactions. 
In order to investigate whether HIV-1 PR has higher contact density than XMRV PR, we 
compared the structures of HIV-1 and XMRV PRs in the opened conformation. We found that all 
studied values were ≥1.5-fold higher for HIV-1 PR, indicating higher contact density (Figure 6C). 
Although full-length flaps are lacking in the studied XMRV PR structure and they do not contribute 
to intermonomeric interactions in HIV-1 PR, the observed differences are caused by the 
characteristics of other regions, mainly by the dimer interface organizations. 
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Figure 6. Comparison of contact maps. (A) Contact maps of HIV-1 PR structures. Structures and 
contact numbers are shown for HIV-1 PR in the closed and opened conformations (orange and red, 
respectively). (B) Contact maps of XMRV PR structures. Structures and contact numbers are shown 
for XMRV PR structures either containing or lacking full-length flaps (light and dark blue, 
respectively). (C) Contact maps of HIV-1 and XMRV PR structures. Structures and contact numbers 
are shown for the opened conformational HIV-1 PR (orange) and for an XMRV PR lacking full-length 
flaps in the crystal structure (blue). (D) Contact maps of Ddi and XMRV PR structures. Structures and 
contact numbers are shown for Ddi PRs (green) and for XMRV PR lacking full-length flaps in the 
crystal structure (blue). In all cases, the structures are represented based on crystal structures. Graphs 
shows intermonomeric contacts for the homodimers based on the PDBsum database. Fold differences 
between the values are shown. In figure part (A), ** indicates that p < 0.01, while ns denotes no 
statistically significant difference. For figure part (B–D), where a single XMRV PR structure (3NR6) 
was used for the comparison, statistical analysis was not performed because the sample number was 
only 1. 
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In contrast with retroviral PRs, the flaps of Ddi proteins do not contribute to dimerization. These 
dimers are instead stabilized mainly by intermonomeric interactions in the dimer interface platform 
[6]. To test this, we compared the contact densities of Ddi proteins with that of XMRV PR lacking full-
length flaps. We expected similar contact numbers for the different PRs, because they all have the 
type II dimer interface and no contacts between the flaps, and the overall interactions were also 
comparable (Figure 4). Interestingly, we found higher contact densities for Ddi PRs than for XMRV 
PR (Figure 6D).  
Although other regions may also be responsible for the observed differences, we studied 
whether N-terminal regions could contribute to intermonomeric interactions. Therefore, we 
compared whether N-terminal regions have different conformations in Ddi and XMRV PRs (Figure 
7). In the crystal structures of XMRV PR, the N-terminus is curved in the direction of the flap elbow, 
but the N-terminal regions in Ddi proteins exhibit extended conformations, being oriented towards 
the other subunit. Based on the PDBsum data, the N-terminal residues of Ddi proteins also form both 
H-bonds and non-bonded interactions with the other subunit. In XMRV PR structures, no H-bonds 
are formed, and the number of non-bonded interactions is lower. Importantly, the involvement of 
these termini in the dimerization was interpreted in the context of the available crystal structures, but 
they may have different conformational states in solution based on small-angle X-ray scattering 
(SAXS) analysis [7]. 
 
Figure 7. Conformations of N-terminal regions are different in Ddi and XMRV PRs. Structures are 
shown based on crystal structures. The side and top views are presented. Ddi and XMRV PR 
structures are indicated in green and blue, respectively, whereas N-termini are colored by magenta 
in all structures. 
The interaction of the N-terminus with the other subunit may be relevant in PRs having type II 
or type III interface because the N-terminal regions are not involved in the formation of the β-sheet 
platform. Consequently, they may have higher flexibility, and they can possibly form 
intermonomeric interactions. It is known that N-terminal extensions have unfavorable effects on the 
activity of HIV-1 PR with a type I dimer interface [83], but the effects of N-terminal regions on the 
activities of epsilon-, gamma-, and spumaretrovirus and non-viral PRs with type II interface have not 
been investigated to date. Additionally, autoproteolysis of Ddi proteins has not been reported, and it 
is possible that the N-terminal regions remain attached, contain no autoproteolytic site, and form a 
connection between the protease domain and the preceding HDD domain, as observed in the 
structures of Ddi2-Hs [6] and Ddi1-Sc [7] PRs. Consequently, the possible conformational states of 
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the N-terminal extensions need to be elucidated in future studies to better understand their putative 
involvement in dimerization. 
2.8. Additional α-Helical Insert 
The presence of an additional α-helical insert was first observed in the crystal structure of EIAV 
PR [26]. This region, which adopts an α-helical conformation, is located in the flap elbow, near the 
conserved active site motif (Figure 1). The structural role of this additional helix has been revealed 
by molecular dynamics simulations suggesting its determinant role in the flexibility of the flaps [8]. 
Despite the relatively higher rigidity of flap movement, the tips of the flaps have high flexibility in 
Ddi PRs, and thus, they are not defined fully in most structures by electron density maps. 
This additional α-helical region exhibits similarity to the vertebrate counterpart pepsin [26], and 
it is not characteristic of most retroviral PRs. Therefore, we investigated whether the helicity of this 
region exhibit characteristic distribution. Although MPMV, HTLV-1, FIV and SFV PRs contain a 310-
helix in the corresponding position, this region adopts an α-helical conformation only in EIAV PR 
among the retroviral PRs, and is present in the structure of Ddi PRs, as well (Figure 2C). 
Based on the currently available structural information, the α-helical insert in the flap elbow is 
present in all known Ddi PR structures. Whereas EIAV PR is the only retroviral protease that contains 
this additional α-helix, it appears that the presence of this helix is not uniquely characteristic for Ddi 
PRs. 
3. Discussion 
Structural studies of retroviral PRs have been reviewed previously [9,69,71], and comparative 
structural analyses of retroviral [70,72,73] and Ddi1-like PRs [13] were also conducted. However, to 
our knowledge a detailed comparative analysis of retroviral and non-viral PRs has not been reported 
previously. Therefore, in this work we studied general and specific structural features of retroviral 
and retroviral-like Ddi1 and Ddi2 PRs, based on structural data currently available in PDB and 
PDBsum databases with a special emphasis on the regions involved in dimer formation. 
In this study, all seven genera of the Retroviridae family were represented at least by one member, 
and eukaryotic Ddi retroviral-like PRs with experimentally determined structures were also 
included. For retroviral PRs, preparation of a homology model was necessary only in the case of 
WEHV-1 PR, as the structural coordinates were available for others. 
Similarly to the specificity patterns of retroviral PRs [70,72,73], we found that overall structural 
features also exhibit characteristics distribution in accordance with the evolutionary relationships. 
The results of multiple sequence and structure alignments were in good agreement with each other 
and reflected the previously established evolutionary relationships of retroviruses [75].  
We classified the dimer interface platforms into three main groups, based on their overall 
organization. Types I and II dimer interfaces are built up by N- and/or C-terminal β-strands, whereas 
type III interface exhibits a completely different structure and helical arrangement of interface-
forming termini. We found that the overall organization of the dimer interface varies among 
retroviral PRs (Figure 8). The type I interface is characteristic of lentiviruses, alpha-, beta- and 
deltaretrovirus PRs, whereas the type II/A interface is characteristic of epsilon- and gammaretrovirus 
PRs. Based on the currently available structures, the six-stranded β-sheet platform (type II/B) is 
characteristic only for non-viral Ddi proteins, and the type III helical interface is a unique feature of 
spumaretrovirus PRs. We assumed that other eukaryotic retroviral-like aspartic proteases have the 
type II/B dimer interface, but this must be elucidated via extensive homology modeling of non-viral 
PRs, which was beyond the scope of this study. 
Based on literature data, the dimer interface organization may be one of the key determinants of 
dimer stability. It was reported previously that the interdigitation of N- and C-terminal strands (as 
observed in HIV-1 PR with the type I interface) may provide a much higher number of 
intermonomeric contacts than observed in PRs with the type II dimer interface, in which the C-
terminal strands exhibit no alternation (e.g., XMRV PR) [46]. In agreement with this hypothesis, 
relatively lower UC50 and higher Kdapp have been reported previously for XMRV PR, implying its 
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lower dimer stability compared with that of HIV-1 PR (Table S1). Our comparison of contact densities 
revealed a good correlation with this observation because XMRV PR had a significantly smaller 
interface area and lower number of contacts than other retroviral PRs (excluding spumaretrovirus 
PRs, which were not included in this comparison). The contact densities of Ddi PRs were highly 
similar to that of XMRV PR (Figure 8), suggesting relatively lower dimer stability for these non-viral 
proteins.  
Comparison of active site motifs revealed the conservation of Thr in the ‘fireman’s grip’ of 
retroviral PRs, excluding foamy virus PRs which contain Ser in this position. Ddi PRs were also found 
to contain mainly Ser in this position. Given that the fact that the Ser residue in the D-T/S-G-A active 
site motif can provide looser ‘fireman’s grip’ interactions than Thr [53,57,77], we assumed that Ddi 
PRs containing D-S-G-A active site motifs may possess lower dimer stability. Nonetheless, other 
regions also contribute to dimer stabilization; thus, the determinant role of the side chain of Ser or 
Thr in dimer stabilization is not exclusive. 
 
Figure 8. Correlation of structural characteristics with evolutionary relationships. The phylogenetic 
tree was obtained via multiple alignment of the protease sequences. The names of retroviruses are 
defined in the list of abbreviations. The features that were characteristic of the different groups are 
shown horizontally (separated by dashed lines). For dimer interfaces, N- and C-terminal β-strands 
are indicated in red and blue, respectively. Sequence logos were prepared on the basis of protease 
sequences of the different groups. The possible occurrence of a salt bridge formed by the fifth residue 
of active site motif is also shown. The presence of additional α-helical inserts is shown, the 310-helices 
are not presented in the figure. For comparisons of contact maps, the values are shown based on the 
PDBsum database for (i) lentivirus, alpha-, beta- and deltaretrovirus PRs, (ii) XMRV PR, and (iii) Ddi 
proteases. *** denotes statistically significant difference (p < 0.001) as compared to the group of 
lentivirus, alpha-, beta- and deltaretrovirus PRs, determined by using PAST v3.26 software. 
We found that the PRs with the type I dimer interface, i.e., in lentiviruses, alpha-, beta- and 
deltaretroviruses, the active site loop contains a highly conserved aspartate residue next to the D-T/S-
G-A motif, the residue of which can form a salt bridge with the other subunit. Interestingly, this salt 
bridge was not observed in PRs possessing type II or III dimer interfaces, whereas in the equivalent 
positions, they contain no charged residue pairs (Figure 8). The formation of salt bridges implies 
stronger intermonomeric contacts, but contradictorily, relatively lower dimer stability was measured 
for HTLV-1 PR (Table S1). 
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The distribution of the G-R-D consensus helix motif was found to resemble that of the Thr 
‘fireman’s grip’ residue. We found that the Arg residue providing an important H-bond with the 
other subunit [79–81] is conserved in the G-R-D consensus helix motifs of all retroviral PRs, excepting 
spumaretrovirus PRs (Figure 8). This important H-bond is missing in Ddi PRs because they 
exclusively contain Leu instead of Arg. Interestingly, Ddi PRs contain Arg or Lys residues in their 
consensus helix, but not in the equivalent position of the helix but close to its C-terminus. These 
positively charged residues can also form H-bond interactions with the other subunit. The 
interactions of the consensus helix are also special in foamy virus PRs, because it does not cover the 
helices of other PRs in its spatial position, and it contains Pro at the position of Arg in the G-R-D 
motif, denoting an entirely different sequence motif. 
The helical arrangement of the region in the proximity of the active site was also studied; 
however, it does not contribute to dimer formation. We found that the presence of the helix is not a 
common feature of retroviral PRs. It adopts an α-helical conformation only in EIAV PR, whereas it 
forms a 310-helix in MPMV, HTLV-1, FIV and SFV PRs. The Ddi PRs of all studied species were found 
to contain the additional α-helix, but it needs to elucidated in future structural studies whether other 
eukaryotic retroviral-like PRs share this feature. 
Possibly, the presence of the additional α-helical insert may be related to the substantially 
different substrate binding mode considered characteristic of Ddi PRs. The conformations of flaps are 
different in Ddi PRs, and they do not resemble those of HIV-1 PR. In the known structures, the flaps 
make the active site accessible to the solvent. The relatively wider substrate cavity is supposed to be 
responsible for recognising secondary or tertiary structure—it permits the binding of smaller 
globular proteins [5,6,8]. Despite the special flap arrangement and larger substrate cavity compared 
with those in HIV-1 and other retroviral PRs, Ddi1-Lm PR exhibited substrate binding and catalytic 
activity [12]. A polypeptide substrate has been modelled to the substrate binding cavity of the 
homodimeric Ddi1-Sc PR, and the structure of the proposed complex indicated that the enzyme can 
bind a polypeptide, despite the lower number of closer enzyme-substrate contacts [5]. The mode of 
the putative substrate engagement was revealed by the crystal structure of Ddi1-Sc PR, and because 
of a crystallization artefact, the N-terminal region of the protein was found to act as pseudo-substrate. 
Therefore, the flaps did not exhibit a closed conformation, and in this binding mode, the pseudo-
substrate was exposed to the solvent [7]. Whereas, the flap elbow of HIV-1 PR provides an opening 
of the flaps, the additional α-helix affects flap movement in Ddi1-Lm PR [8], and it may be a structural 
determinant of substrate engagement. 
In conclusion, our results suggest that the organization of dimer interface is a main determinant 
of the intermonomeric interactions, and the distribution of characteristics of the regions involved in 
dimer formation is in accordance with the evolutionary relationships, not only among retroviral 
proteases but also relative to retroviral-like Ddi proteases. The homodimerization of Ddi1 and Ddi2 
proteases have already been proved either by X-ray crystallography or SAXS [5–8,84], but 
characteristics of dimerization, especially in vitro dimer stabilities (e.g., UC50 and Kdapp values) are 
available in the literature only for some PRs having type I or type II/A interface, but not for enzymes 
having type II/B interface organization. Our results imply that non-viral retroviral-like PRs 
potentially have relatively lower dimer stability compared to retroviral counterparts. We assume that 
getting better insight into the structural requirements for the dimer formation through the protease 
domain may help understanding the roles of Ddi-like proteins in proteasomal shuttles and 
ubiquitination pathways [6,7,63,64,67,68,84,85], even in physiological or pathological conditions. 
Furthermore, future studies are needed to prove our findings by determining the in vitro dimer 
stabilities, and correlating the features described in our study with those of additional eukaryotic 
retroviral-like or endogenous retrovirus PRs. 
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4. Materials and Methods  
4.1. Data 
Protease sequences were obtained from previous comparative analyses [72,73] and from the 
UniProt knowledgebase (https://www.uniprot.org) [86]. The identifiers of the studied proteases are 
listed in Table S4. Coordinate files were downloaded from the Protein Data Bank 
(http://www.rcsb.org) [87]. Contact maps were downloaded from the PDBsum database 
(http://www.ebi.ac.uk/pdbsum) [88]. The protease structures used for comparison are listed in Table 
S2. 
4.2. Analysis 
Multiple sequence alignment was performed using Clustal X v1.83 [89]. Phylogenetic tree was 
built using the Interactive Tree Of Life web server (iTOL, https://itol.embl.de) [90]. Sequence logos 
were prepared by WebLogo 3 web server (http://weblogo.threeplusone.com/create.cgi) [91]. 
Secondary structure predictions were performed using GORIV (https://npsa-prabi.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_gor4.html) [92] and JPred4 
(http://www.compbio.dundee.ac.uk/jpred) [93] servers. The SWISS-MODEL server 
(https://swissmodel.expasy.org) was used for homology modeling of WEHV-1 PR [94], using the 
crystal structure of XMRV PR as template (PDBID: 3SM1). Multiple protein structure alignment was 
performed by using mTM-align web server (http://yanglab.nankai.edu.cn/mTM-align) [74]. Structural 
figures were prepared using the PyMOL Molecular Graphics System (Version 1.3, Schrödinger, LLC, 
Portland, OR, USA). Statistical analysis was performed by the PAST v3.26 software, using Mann–
Whitney pairwise algorithm (several-sample tests) [95].  
Supplementary Materials: The following are available online at www.mdpi.com/1422-0067/21/4/1352/s1. 
Author Contributions: Conceptualization, J.A.M. and J.T.; methodology, J.A.M., M.M., and J.T.; software, J.A.M. 
and M.M.; validation, J.A.M. and J.T.; formal analysis, J.A.M. and M.M.; data curation, J.A.M. and M.M.; 
writing—original draft preparation, J.A.M., M.M., and J.T.; visualization, J.A.M. and M.M.; supervision, J.A.M. 
and J.T.; funding acquisition, J.T. 
Funding: This research was supported in part by the GINOP-2.3.2-15-2016-00044 “PHARMPROT teaming” 
project and by the Higher Education Institutional Excellence Programme (NKFIH-1150-6/2019) of the Ministry 
of Innovation and Technology in Hungary, within the framework of the Biotechnology thematic programme of 
the University of Debrecen, and by EFOP-3.6.3-VEKOP-16-2017-00009 project. 
Acknowledgments: Authors are grateful for the members of the Laboratory of Retroviral Biochemistry. Authors 
thank V.O. from the Department of Botany (University of Debrecen, Faculty of Science and Technology) for his 
support in statistical analyses. 
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the 
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to 
publish the results. 
Abbreviations 
AMV Avian myeloblastosis virus 
BAEV Baboon endogenous virus 
BFV Bovine foamy virus 
BIV Bovine immunodeficiency virus 
BLV Bovine leukemia virus 
CAEV Caprine arthritis encephalitis virus 
Ddi1-Lm DNA damage-inducible protein 1 (Leishmania major) 
Ddi1-Sc DNA damage-inducible protein 1 (Saccharomyces cerevisiae) 
Ddi1-Hs DNA damage-inducible protein 1 (Homo sapiens) 
Ddi2-Hs DNA damage-inducible protein 2 (Homo sapiens) 
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